Skip to Content

McKesson Corporation (NYSE: MCK)

Merger

  • Date:
  • 11/14/2019
  • Company Name:
  • McKesson Corporation
  • Stock Symbol:
  • MCK
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

NEW YORK, November 14, 2019 –Bragar Eagel & Squire is investigating certain officers and directors of McKesson Corporation (NYSE: MCK) following a class action complaint that was filed against McKesson Corporation on October 25, 2018.

The complaint alleges that throughout the class period defendants made false and/or misleading statements and/or failed to disclose that: (i) McKesson and several of its industry peers colluded to fix the price of certain generic drugs; (ii) the collusive conduct constituted a violation of federal antitrust laws; (iii) consequently, McKesson's revenues during the Class Period were, in part, the result of illegal conduct and were therefore unsustainable; (iv) McKesson lacked effective internal controls over financial reporting; and (v) as a result, McKesson's public statements were materially false and misleading at all relevant times.

If you  are a long -term stockholder of McKesson Corporation shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 308-5858, or by filling out the form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in McKesson Corporation. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: